Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis

Background: Monoamine oxidase B (MAO-B) inhibitors and dopamine receptor agonists are common first-line treatment options in early Parkinson’s disease (PD). Objective: To evaluate the efficacy and safety of rotigotine transdermal patch as an add-on therapy to an MAO-B inhibitor in patients with earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Giladi, Nir, Asgharnejad, Mahnaz, Bauer, Lars, Grieger, Frank, Boroojerdi, Babak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927859/
https://www.ncbi.nlm.nih.gov/pubmed/27061066
http://dx.doi.org/10.3233/JPD-150758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927859/
https://www.ncbi.nlm.nih.gov/pubmed/27061066
http://dx.doi.org/10.3233/JPD-150758

Ejemplares similares